Pancreatic β-cells maintain glucose homeostasis by their regulated Ca2+-dependent secretion of insulin. Several cellular mechanisms control intracellular Ca2+ levels, but their relative significance in mouse β-cells is not fully known. We used photometry to measure the dynamics of cytosolic Ca2+ ([Ca2+]i) clearance after brief, depolarization-induced Ca2+ entry. Treatment with thapsigargin or cyclopiazonic acid, inhibitors of the sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) pumps, nearly doubled the peak and slowed the decay of the depolarization-induced Ca2+ transients. The remaining thapsigargin-insensitive decay was slowed further by inhibition of the plasma membrane Ca2+-ATPase (PMCA) and plasma membrane Na+/Ca2+ exchanger (NCX) via alkalization of the bath solution, by adding lanthanum, or by substitution of Na+ with Li+. Mitochondrial Ca2+ uptake contributed little to clearance in thapsigargin-pretreated cells. Together, the SERCA, PMCA, and NCX transport mechanisms accounted for 89 to 97% of clearance in normal solutions. We developed a quantitative model for the dynamic role of removal mechanisms over a wide range of [Ca2+]i. According to our model, 50 to 64% of initial Ca2+ removal is via the SERCA pump, whereas the NCX contributes 21–30% of the extrusion at high [Ca2+]i, and the PMCA contributes 21–27% at low [Ca2+]i.
The central importance of glucose homeostasis has drawn attention to the cell physiology of pancreatic β-cells. Insulin released from β-cells lowers blood glucose and facilitates glucose storage. Insufficient insulin secretion leads to diabetes. Several signal molecules modulate insulin secretion from β-cells (1), including cAMP (2), protein kinase A (3,4), protein kinase C (3,5), glutamate (6), malonyl-CoA (7,8), and insulin itself (9,10). However, cytosolic free Ca2+ ([Ca2+]i) is the dominant player in glucose-insulin-secretion coupling. Following a nutrient stimulus, β-cells depolarize, thereby causing the opening of voltage-gated Ca2+ channels. This leads to a brisk increase in calcium entry that initiates the exocytosis of insulin-containing granules. Hence, understanding intracellular Ca2+ dynamics is central for understanding insulin secretion.
As for other animal cells, four mechanisms remove Ca2+ from the cytosol of β-cells: the plasma membrane Na+/Ca2+ exchanger (NCX), plasma membrane Ca2+-ATPase (PMCA), sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) pumps, and the calcium uniporter of mitochondria (11–15). Together with cytosolic Ca2+ buffers, they determine the characteristics of [Ca2+]i clearance. Many studies have examined these mechanisms, but it is not known how much each contributes to calcium removal in β-cells, which is the focus of our study.
We induced Ca2+ loads in mouse pancreatic β-cells by short membrane depolarizations while monitoring changes of the cytosolic free Ca2+. Agents were applied to block each of the potential clearance mechanisms selectively. Our results show that the SERCA pumps dominate the clearance after depolarization.
RESEARCH DESIGN AND METHODS
Chemicals.
Indo-1-AM, pluronic 147, and BCECF-AM were from Molecular Probes (Eugene, OR), and thapsigargin (TG) and cyclopiazonic acid (CPA) were from Calbiochem (La Jolla, CA). Culture medium, serum, and antibiotics were from Invitrogen (Carlsbad, CA), and all other chemicals from Sigma (St. Louis, MO).
Cell preparation.
Animal care followed the University of Washington Animal Medicine guidelines. The pancreas was removed from male Balb/c mice (4–7 weeks old) killed with CO2 (16), and islets of Langerhans were obtained by incubating small pancreatic pieces for 35 min in modified Hank’s buffered solution, containing 5 mg/ml collagenase P (Boehringer, Germany), 1 mg/ml BSA, 20 mmol/l HEPES, and 10 mmol/l glucose. Single cells were dispersed by shaking islets in Ca2+-free Hank’s buffered solution containing 1 mmol/l EGTA, 5 mmol/l glucose, and 10 mg/ml BSA. Isolated cells plated on coverslips precoated with poly-ornithine were kept in a 37°C, 5% CO2 incubator for 2–5 days in RPMI-1640 culture medium containing 10 mmol/l glucose, 10% FBS, 100 μg/ml streptomycin, and 100 IU/ml penicillin. Results were the same on culture days 2–5. Non-β-cells were excluded by selecting the larger cells (17). Frequent tests showed that these cells respond to high glucose with Ca2+ elevations and secretion (by amperometry).
Solutions.
The control bath solution (called Na7.4) contained NaCl 130 mmol/l, KCl 2.5 mmol/l, CaCl2 2 mmol/l, MgCl2 1 mmol/l, HEPES 10 mmol/l, glucose 15 mmol/l, and diazoxide 250 μmol/l (pH 7.4 with NaOH). We included high glucose to mimic clearance under nutrient stimulus and diazoxide to minimize changes of the resting potential due to variations of cytoplasmic ATP. The experiments involved rapid changes (<500 ms) of solution by a fast local perfusion system controlled digitally. Except in Figs. 1, 5, and 7, depolarization and Ca2+ entry were evoked by 3-s applications of high K+ solution containing KCl 70 mmol/l, NaCl 67 mmol/l, CaCl2 2 mmol/l, MgCl2 1 mmol/l, HEPES 10 mmol/l, glucose 15 mmol/l, and diazoxide 250 μmol/l (pH 7.4 with KOH). The KCl solution was followed by test solutions designed for selective study of specific Ca2+ clearance mechanisms. The test solutions were named by their principal cation and pH. Thus, to inhibit the NCX, we used Na+-free solution with Li+ replacing Na+ (Li7.4). To slow the PMCA pump, we raised the pH 8.8 (Na8.8) (18) or added 200 μmol/l LaCl3 (NaLa7.4) (19). Solutions Li8.8 and LiLa7.4 combined conditions to block two transporters. Other transport blockers were added to the Na7.4 bath solution. Flowing solutions were maintained at 35°C in all experiments with a heat exchanger.
Optical measurement of [Ca2+]i and pH.
Cytosolic Ca2+ was monitored with indo-1 (20). Briefly, cells were loaded with indo-1-AM (10 μmol/l) at room temperature for 20–25 min in a bath solution containing 4 mmol/l glucose. Sometimes, the loading solution also contained 1 μmol/l TG to block SERCA pumps. During [Ca2+]i measurements, the dye was excited by 365 nm light, and two photomultipliers collected emission at 405 and 500 nm, respectively. The standard calibration parameters (21), Rmin (0.406), Rmax (4.8), and K* (2.688 μmol/l), were determined from cells equilibrated in KCl-based internal solutions containing ionomycin (10 μmol/l) and 20 mmol/l EGTA, 15 mmol/l CaCl2, or 20 mmol/l EGTA with 15 mmol/l CaCl2 (251 nmol/l free Ca2+).
Cytosolic pH was monitored similarly in cells loaded with the ratiometric indicator BCECF-AM (1 μmol/l) for 20–25 min in standard bath solution (22). Excitation light at 440 and 490 nm was provided by a computer-controlled monochromator (T.I.L.L., Germany), and emitted light at 520 nm was collected by a photodiode. Calibration involved bathing cells in KCl-based “internal” solutions containing nigericin (10 μmol/l) at pH 5, 7, and 9 with 10 mmol/l MES, HEPES, or CHES buffers, respectively.
In the experiments of Fig. 5, Ca2+ dynamics were studied at 35°C in cells under whole-cell voltage clamp. The cells were held at −80 mV, and the pipette contained 100 μmol/l indo-1 dye and 75 mmol/l Cs2SO4, 15 mmol/l CsCl, 50 mmol/l HEPES, 6.5 mmol/l NaCl, 2.5 mmol/l sodium pyruvate, 2.5 mmol/l malate, 1 mmol/l NaH2PO4, 1 mmol/l MgSO4, 5 mmol/l MgATP, and 0.3 mmol/l tris-GTP (pH 7.3 with CsOH). Calcium loading was induced in a bath medium containing 10 mmol/l Ca2+ and 10 mmol/l tetraethylammonium ion by stepping the membrane potential to 0 mV for only 300–400 ms. Potentials were corrected for a −10 mV junction potential.
Amperometric measurement of vesicular secretion.
Cells were preincubated in culture medium supplemented with the oxidizable neurotransmitter serotonin (1.5–2 mmol/l) for 7–14 h (23). A carbon-fiber electrode (24) was connected to an EPC-9 patch clamp amplifier (HEKA, Lambrecht, Germany) and held at 600 mV. Serotonin coreleased from individual insulin-containing granules was detected by the electrode as spikes of oxidation current.
Calculations.
Data were analyzed and modeled in Igor Pro (Wavemetrics, Lake Oswego, OR). Averaged results are given as means ± SE. Statistical significance was assessed using unpaired Student’s t test. The rate equations of a kinetic model given later were integrated numerically by the Euler method (first-order integration) in time steps of 0.5 s (see also online appendix).
RESULTS
Delayed release of Ca2+ from stores.
The experiments measured the time course of [Ca2+]i decay following depolarization-induced Ca2+ loads. Ideally, by selectively inhibiting specific clearance mechanisms, one could determine the contribution and rate laws of each mechanism. An important assumption of this approach is that the evoked delivery of Ca2+ to the cytoplasm stops as soon as the Ca2+-loading depolarization is over. Past work on β-cells with slow perfusion and ≥30 s KCl depolarizations had shown that Ca2+ entry could be followed by a delayed release of Ca2+ from the endoplasmic reticulum (ER) that lasts >1 min (25,26). Therefore, our first experiments explored how to minimize this interfering phenomenon.
Figure 1A shows [Ca2+]i measurements as the 70 mmol/l K+ depolarizing solution is applied repeatedly to a single β-cell for times ranging from 3 to 30 s. The [Ca2+]i rises steeply during each depolarizing stimulus and then falls as transporters clear it away from cytosol. The falling phases are aligned and superimposed on a faster time scale in Fig. 1B and C. Consider the first four test depolarizations in which none of the clearance mechanisms is inhibited: after the 3- and 10-s depolarizations, the decay of [Ca2+]i is monotonic, and [Ca2+]i returns to its resting level with an exponential time constant <2 s. After the 20- and 30-s depolarizations, recovery is not monotonic and shows a hump indicative of a delayed Ca2+ release. However, the decay becomes monotonic in the second half of the experiment (Fig. 1A and C), where the SERCA pumps are inhibited with CPA. Evidently, the delayed Ca2+ release requires prior filling of the ER stores (25) and does not occur without a large Ca2+ load or when SERCA pumps are blocked. In all subsequent experiments, we prevented the delayed Ca2+ release by using short (3 s) exposures to the depolarizing solution and, often, by preincubating the cells with the irreversible SERCA pump inhibitor TG as well.
The experiments of Fig. 1 suggest that considerable Ca2+ removal occurs during longer depolarizing pulses. At the end of 10-, 20-, and 30-s depolarizations, [Ca2+]i is lower (see arrows) than after a 3-s depolarization, because voltage-gated Ca2+ channels inactivate enough within a few seconds (27) that the entry rate during the pulse falls below the clearance rate. Thus, depolarizing for only 3 s allowed us to study clearance starting at a higher initial [Ca2+]i level in a cell whose intracellular organelles did not already have a large Ca2+ load.
SERCA pumps dominate Ca2+ clearance.
The contribution of SERCA pumps to Ca2+ clearance was assessed by comparing [Ca2+]i decay before and after inhibition with CPA or TG. With 3-s depolarizations, these inhibitors increased the peak amplitude of the Ca2+ transients and slowed their subsequent decay (Figs. 1 and 2A). Thus, SERCA pumps are important in removing Ca2+ both during the 3 s of depolarization and in the subsequent recovery. Consider the averaged traces in Fig. 2A. Inhibition of SERCA pumps doubles the peak Ca2+ evoked by depolarization, from 1.06 ± 0.07 μmol/l (n = 35) in control cells to 2.05 ± 0.04 μmol/l (n = 130) in TG-pretreated cells.
Rates of Ca2+ increase during the depolarization and rates of Ca2+ decrease during the recovery are plotted as a function of [Ca2+]i in Fig. 3A. These points are derived from the time derivatives of the averaged traces of Fig. 2A. TG pretreatment elevated the rate of rise of [Ca2+]i during the depolarization from 0.41 to 0.85 μmol · l−1 · s−1 at 0.48 μmol/l [Ca2+]i and reduced the rate of decay during the recovery from ∼0.32 to 0.1 μmol · l−1 · s−1 at 0.48 μmol/l [Ca2+]i. Thus SERCA pumps remove about two-thirds of the Ca2+ load during the depolarization and recovery. The same conclusion is reached by fitting the falling phase of the Ca2+ transients with single exponential functions. Compared with control cells, TG pretreatment prolongs the recovery time constant τ, from 1.7 ± 0.1 to 4.6 ± 0.1 s, a 63% reduction of the rate of clearance (Fig. 3B).
As a further check that these results were not contaminated by excessive loading of the ER, we repeated the experiments on cells under whole-cell voltage clamp using brief (300–400 ms) step depolarizations and 100 μmol/l indo-1 inside. The bathing [Ca2+]i was raised to 10 mmol/l to enhance the rate of entry during these shorter depolarizations. The clearance time constant (1.0 ± 0.1 s) (Fig. 3B) was slightly shorter than in intact cells, and the effect of TG was virtually the same as in intact cells (τ = 4.4 ± 0.3 s). The shorter time constant in whole-cell recording can be explained largely by the lower cellular indo-1 concentration under whole-cell recording (see below, “Relative contributions to Ca2+ clearance and a model”).
Contributions of the NCX and PMCA in TG-pretreated cells.
Subsequent experiments were done with cells pretreated with TG to block SERCA pumps, permitting better resolution of other slower clearance mechanisms. To stop forward operation of the NCX, we replaced all Na+ with Li+ (28). After a control KCl depolarization, cells were washed with control solution for 150 s, and after a second depolarization, they were exposed to the Li7.4 solution for 100 s. Aligning averaged traces to the start of the depolarization shows that the Li7.4 solution slows the initial rate of Ca2+ clearance (Fig. 2C, Li7.4). Turning off the NCX lengthens the recovery time constant from 4.6 ± 0.1 to 8.9 ± 0.5 s (Fig. 3B), a 48% reduction of clearance in these TG-pretreated cells. A blocker of reverse-mode (Ca2+ influx) operation of the NCX, KB-R7943 (5 μmol/l), did not affect Ca2+ clearance time course in TG-pretreated cells (data not shown).
Two approaches were used to block the PMCA. Because the PMCA exports one cytosolic Ca2+ in exchange for one or two extracellular protons, lowering the proton concentration in the bath slows pumping (18). We found that raising the pH in the bath solution to 8.8 (Na8.8) slowed especially the late phase of Ca2+ clearance (Fig. 2C). Because alkalization might alter Ca2+ clearance in other ways than blocking the PMCA, we also used another blocker, La3+, at 0.2 mmol/l, a concentration reported to inhibit the PMCA but not the NCX (19). When La3+ was added to the bath solution (NaLa7.4), the initial kinetics of recovery (Fig. 2E) were similar to those observed in Na8.8 solution (Fig. 2C), but below 0.5 μmol/l Ca2+, the NaLa7.4 trace returned more quickly to the basal level. The recovery time constants in Na8.8 and NaLa7.4 solutions were 6.4 ± 0.5 and 5.9 ± 0.5 s, respectively, in comparison to a control value of 4.6 ± 0.1 s in TG-pretreated cells (Fig. 3B), a 40 or 28% additional slowing of Ca2+ clearance rates. Modeling shown below suggests that the difference represents less blockade of the PMCA by 0.2 mmol/l La3+. As reported by others (19), higher concentrations of La3+ seemed to inhibit both the NCX and the PMCA and were not explored further.
To test whether the SERCA, PMCA, and NCX mechanisms together account for most of the clearance from β-cells, we blocked all three of them simultaneously. The cells were pretreated with TG and then switched to a Na+-free Li+ solution either with high pH (Li8.8) or with 0.2 mmol/l La3+ (LiLa7.4) immediately after depolarization by KCl. The Li8.8 solution slowed the recovery dynamics extremely (Fig. 2C), indicating that the three transport mechanisms account for almost all of the normal clearance. As expected, the LiLa7.4 solution slowed recovery also, but not as much (Fig. 2E).
A possible artifact of bath alkalization or sodium substitution is to increase intracellular pH and thereby alter other clearance mechanisms. We therefore measured cytosolic pH with the indicator BCECF. Indeed, switching to the alkaline extracellular solution (Na8.8) did increase intracellular pH of BCECF-loaded cells but only by about 0.45 ± 0.06 units, to pH 7.2 within 20 s (n = 6) (Fig. 4A). Replacement of Na+ with Li+ induced no pH changes. The following control experiments show that a 0.4-unit intracellular pH increase does not affect the PMCA or the NCX: we found that a bath solution containing 20 mmol/l NH4Cl produces an intracellular pH increase similar to that of Na8.8 (Fig. 4B) (22), without altering Ca2+ clearance in TG-pretreated cells (Fig. 4C).
Lack of effects of mitochondria in TG-pretreated cells.
Is there a role of mitochondria in Ca2+ clearance of TG-pretreated cells? Mitochondrial Ca2+ uptake is driven by the large mitochondrial membrane potential (negative inside), so the standard approach to stop Ca2+ uptake is to collapse the mitochondrial membrane potential with a protonophore like carbonyl cyanide m-chloro-phenylhydrazone (CCCP). A possible artifact is that cellular ATP is gradually depleted, so the PMCA and SERCA pumps might be slowed. As this could happen in intact β-cells despite the short time of our experiments, we did experiments on TG-pretreated cells under whole-cell voltage clamp with 5 mmol/l ATP in the pipette, as well as on intact cells. In either case, 50-s CCCP treatments did not change the exponential time constants of Ca2+ decay (Figs. 3B and 5A). For intact cells, the resting Ca2+ level was very slightly elevated with 2 μmol/l CCCP plus 2.5 μmol/l oligomycin, but the time constant (4.6 ± 0.3 s) was the same as in TG-pretreated control cells (4.6 ± 0.1 s), and for clamped cells, the time constant with 2 μmol/l CCCP was 5.1 ± 0.4 s, not significantly different from control (4.4 ± 0.3 s). Thus, we conclude that mitochondrial Ca2+ uptake is not a major contributor to the Ca2+ clearance we see after 0.3- to 3-s depolarizations. Nevertheless, a puzzling finding was that CCCP raised resting [Ca2+]i and slowed clearance by 15% (P = 0.16, NS) in intact and 45% (P = 0.006) in clamped cells not pretreated with TG (Fig. 3B). This slowing could be a sign of local ATP depletion during CCCP treatment and might reflect some close interaction of mitochondria with the ER or a lack of specificity of the inhibitors, but we lack a clear explanation. The lack of effect of CCCP on TG-pretreated cells is not likely a block of mitochondrial uptake by TG, since the same effect was seen with CPA-treated intact cells.
Relative contributions to Ca2+ clearance and a model.
We now consider a more quantitative analysis. Clearance rates at each Ca2+ level were estimated from the measured slopes of the decay phase. Table 1 summarizes the relative contribution of each clearance mechanism as defined by use of inhibitors and calculated at four concentrations of [Ca2+]i. The SERCA pumps dominate. After SERCA pumps are inhibited, the NCX contributes relatively more to the clearance at high [Ca2+]i, whereas the PMCA contributes more at low [Ca2+]i. The sum of these three mechanisms accounts for 89–97% of the Ca2+ removal within the whole range of our tests.
Using these values, we developed a mathematical description of the three principal clearance mechanisms to simulate our experimental records (Fig. 2B, D, and F). We took conventional rate laws and values of coefficients from the literature for other cells where possible, and scaled the relative maximum fluxes to best correspond with our observations.
SERCA pumps were simulated by a saturating function with a Hill coefficient of 2.0:
where M is the Ca2+ flux. β-Cells express both the ubiquitous SERCA2b and the low-affinity SERCA3 pumps (13,14). For the half-saturating Ca2+ concentration (KSERCA), we took a value for SERCA2b, 0.27 μmol/l (29). The PMCA was represented by simple Michaelis-Menten kinetics:
with half-saturating concentration (KPMCA) of 0.50 μmol/l (28) multiplied by a titration function expressing the activation of pumping by protons with a pKa of 7.86 (18). Bidirectional transport by the NCX is computed according to a complex rate equation derived from experiments on electrogenic transport in cardiac myocytes (28). For the NCX calculation, it was also necessary to model a time-varying intracellular concentration of Na+, an obligate substrate of the exchanger. The model also had a small resting inward leak of Ca2+ from the bath through unspecified ion channels, and it assumed that the cytoplasm has an endogenous calcium binding ratio of 100:1 as well as additional Ca2+ buffering contributed by the indo-1 dye. We estimated the dye concentration in intact cells loaded by the indo-1-AM method by comparing the intensity of their fluorescence with the intensity of cells studied by whole-cell pipette with 100 μmol/l indo-1 in the pipette. By this method, the intact cells contained on average 188 μmol/l indo-1. This amount of dye raises the Ca2+ binding ratio from 100 to 178 when the free [Ca2+]i is 500 nmol/l. The assumption of a Ca2+ binding ratio allows us to translate the observed rate of change of free [Ca2+]i (units of moles per liter per second) into total calcium molar fluxes across the plasma or ER membranes of a liter of β-cells (units of moles per second). Errors in this assumption would scale the fluxes; i.e., if the total buffer is actually double that assumed, the fluxes would need to be doubled.
The relative flux rates of the model (Fig. 6 legend) were chosen so that the predicted time constants of clearance (Fig. 3B, ○) agreed with the experimental values (Fig. 3B, bars). The full Ca2+ time courses predicted from the model are shown in the righthand panels of Fig. 2. Comparison to the original data shows generally good agreement with the effects of various inhibitors. The simulated decay of [Ca2+]i has an exponential time constant of 1.51 s for intact cells with 188 μmol/l indo-1, 1.43 s for whole-cell recording with 100 μmol/l indo-1 (and 10 Ca2+ outside), and 1.11 s for the physiological state when cells contain no dye (simulating a “physiological” state we could not measure experimentally). In the simulations of intact cells, KCl treatments were represented as 3-s depolarizations from −70 to −10 mV with a 350-fold enhanced Ca2+ influx rate. TG was assumed to turn off SERCA pumps fully. Inhibition of the PMCA was 86% at pH 8.8 (18), and only 62% by La3+ (assumed). Figure 6 summarizes the predicted clearance rates of each of the transport mechanisms as given by the model. The SERCA pumps account for about 60–70% of the clearance at all [Ca2+]i levels and the PMCA and NCX account for the remainder.
SERCA pumps limit depolarization-induced secretion.
Because inhibition of SERCA pumps significantly increased and prolonged depolarization-induced Ca2+ transients, we reasoned that it should also increase depolarization-induced exocytosis from the cell. Figure 7 shows [Ca2+]i and amperometric recordings of exocytosis from β-cells during 10-s KCl depolarizations. Each current spike in the amperometric records indicates exocytosis of a single serotonin-containing secretory granule (see research design and methods). In a single cell (Fig. 7B) or a small cluster of cells (Fig. 7C), addition of CPA dramatically and reversibly raised the [Ca2+]i level reached and increased the rate of exocytosis evoked by a long depolarization. On average, CPA increased exocytosis to 5.3 ± 1.0 times the control (n = 24).
DISCUSSION
Several observations reveal that SERCA pumps can remove cytoplasmic Ca2+ faster than the other transport mechanisms in dissociated pancreatic β-cells. Inhibitors of SERCA pumps increase the rate of rise and the size of depolarization-induced Ca2+ transients (3-s depolarizations), lengthen the time constant of decay, slow the rate of clearance, and increase the exocytotic response. The simplest approach to quantitation treats clearance as a first-order process, e.g., for clearance time constants of 1.7 s in intact calls (or 1.0 s in whole-cell clamp), the overall clearance rate constant would be 0.61 (or 1) s−1. This would represent the sum of all clearance mechanisms acting in parallel. Addition of CPA or pretreatment with TG has similar effects on the two preparations; the time constants lengthen to 4.6 s (or 4.4 s). Thus, the rate constant of all non-SERCA clearance (mostly PMCA and NCX) is 0.22 (or 0.23) per second and that for SERCA clearance is 0.39 per s (or 0.77 per second with 5 mmol/l ATP in the pipette). In both cell preparations, the SERCA pump is faster than all others put together. The same result is seen in Fig. 6, which plots the modeled molar Ca2+ pumping rate for each of the three clearance mechanisms we found in intact cells. At all [Ca2+]i concentrations >100 nmol/l, the SERCA pump is the fastest. Our results agree well with a previous report that TG prolongs the Ca2+ clearance time constant from 1.8 to 4.6 s in mouse β-cells and that Na+-free solution has a much smaller effect, changing time constants from 2.0 to 2.6 s (30).
β-Cells cannot accomplish their physiological role using SERCA pumps alone. There is significant Ca2+ entry across the plasma membrane lasting many seconds during normal episodic insulin secretion. Although the SERCA pumps might continue to transport rapidly, efflux from the filling ER will soon counterbalance this clearance mechanism. In the long run, Ca2+ has to be pumped out of the cell rather than being accumulated in intracellular stores. Fortunately, there is an appreciable TG-insensitive component of clearance consisting at least of the PMCA and the NCX. Even in TG-pretreated cells exposed to Na+-free solution that would stop the NCX, the [Ca2+]i still returns fully to resting levels after a Ca2+ load. We confirm the observation of several groups (25,26) that following a round of Ca2+ clearance, the ER spontaneously returns a considerable amount of Ca2+ to the cytoplasm, lowering the ER content and prolonging the late phase of cytoplasmic clearance. This delayed release may reflect a combination of Ca2+-induced Ca2+ release and rebalancing of the steady-state filling of the ER once [Ca2+]i falls to low levels. It is potentially very significant during physiological secretion and deserves further quantitative investigation.
The relative contribution of the PMCA to Ca2+ clearance in β-cells has not been clearly established because of a lack of specific inhibitors. The criteria we used here have some drawbacks. High pHo might change intracellular pH (and we have controlled for that), and it is known in other cells to enhance passive Ca2+ influxes in several voltage-gated Ca2+ channels by relieving proton block (31) and to depress the NCX (pH 10 depresses NCX by 51% [32]). Lanthanum has only a narrow window of usefulness as a specific agent since, at concentrations not quite sufficient to block the PMCA, it begins to block the NCX and to accumulate inside cells (19). Nevertheless, our results with the two methods are self-consistent with the overall partitioning of transport components obtained by use of these inhibitors and TG- and Na+-free solutions. Several PMCA isoforms and several NCX isoforms are expressed in rat and human pancreatic β-cells and related cell lines (11,12,15).
Glucose and KCl can induce changes of mitochondrial membrane potential in pancreatic β-cells (33) and of mitochondrial Ca2+ concentration in a β-cell line (34). Hence, β-cell mitochondria, like those of other cells, transport Ca2+. In the β-cell, however, we find that this transport rate is slower than that of the SERCA, PMCA, and NCX mechanisms, so by itself it does not contribute to the overall time course of clearance.
Another consideration is that emptying of ER stores by treatment with CPA or with inositol-trisphosphate-inducing agonists is reported to elicit store-operated inward calcium current in pancreatic β-cells (35,36). This could slow the apparent time course of clearance and lead to an underestimation of the clearance rates. In our TG-pretreated cells, the baseline [Ca2+]i was only 12% higher than in untreated cells, so we suggest that any store-operated calcium current in our experiments is quite small relative to the other sources of Ca2+ leak and would not significantly alter our results.
In conclusion, our experiments and modeling provide a quantitative description of the Ca2+ clearance mechanisms of mouse pancreatic β-cells bathed in a saline solution with high glucose. Clearance is quite fast, and the initial phase is dominated by SERCA pumps. We demonstrate the significance of SERCA pumps in regulating excitation-secretion coupling. It is probable that several of the transport mechanisms studied here could be altered by lowering the glucose concentration or by adding neurotransmitters to initiate intracellular signaling cascades. These conditions merit investigation. More work is also required to clarify the dynamic contributions of delayed Ca2+ release from the ER and to determine the endogenous Ca2+ binding ratio to calibrate the absolute flux rates of the transport mechanisms. These findings will be important to facilitate better understanding and prediction of insulin secretion.
[Ca2+]i . | 0.5 μmol/l . | 0.9 μmol/l . | 1.5 μmol/l* . | 1.9 μmol/l . |
---|---|---|---|---|
SERCA pumps | 68 | 61 | † | † |
PMCA pumps | 16 | 12 | 30† | 35† |
NCX | 13 | 16 | 63† | 62† |
Total accounted for | 97 | 89 | 93† | 97† |
[Ca2+]i . | 0.5 μmol/l . | 0.9 μmol/l . | 1.5 μmol/l* . | 1.9 μmol/l . |
---|---|---|---|---|
SERCA pumps | 68 | 61 | † | † |
PMCA pumps | 16 | 12 | 30† | 35† |
NCX | 13 | 16 | 63† | 62† |
Total accounted for | 97 | 89 | 93† | 97† |
Data are %.
The rate of [Ca2+]i decay, d[Ca2+]i/dt, was determined at four [Ca2+]i levels from averaged records. Table shows the percentage of the rate that was inhibited by appropriate blocking conditions.
Values from TG-pretreated cells, which represent the percentage contribution of the PMCA and NCX to the clearance (by the Na8.8 and Li7.4 methods) when SERCA pumps are disabled.
Additional information for this article can be found in an online appendix at http://diabetes.diabetesjournals.org.
Article Information
This work was supported by National Institutes of Health (NIH) Grant AR17803, by a Pilot and Feasibility Award from the University of Washington Diabetes Endocrinology Research Center (NIH Grant DK17047), and by KOSEF Grant R01-00285 (Korea).
The authors thank Fernando Santana, Donner Babcock, Lea Miller, and Jie Zheng for their helpful comments on the manuscript and Josep Vidal for advice with the β-cell preparation.